Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why Is Actelion Suppressing Phase III Data?
Forbes
Friday, December 6, 2013 - 5:49pm
tags:
Actelion, almorexant, insomnia
High-Risk Pipeline Candidates and Limited Options Make Novartis an Iffy Buy Candidate
Motley Fool
Friday, December 6, 2013 - 5:48pm
tags:
Novartis
FDA approves first drug option for rare disease that causes painful, curved erections in men
Yahoo/AP
Friday, December 6, 2013 - 5:44pm
tags:
Peyronie's Disease, FDA, Auxilium, Xiaflex
Belviq Sales During The Holiday Week
Seeking Alpha
Friday, December 6, 2013 - 5:42pm
tags:
Arena Pharmaceuticals, Belviq, Eisai
Gilead Wins FDA Approval for Blockbuster Hepatitis C Pill
Bloomberg
Friday, December 6, 2013 - 5:41pm
tags:
sofosbuvir, FDA, Gilead Science, hepatitis C, Sovaldi
AstraZeneca is first to win EU approval for an inhaled 4-in-1 flu vaccine
Fierce Pharma
Friday, December 6, 2013 - 11:57am
tags:
vaccines, Europe, Flu, flu vaccines, AstraZeneca, Fluenz Tetra
Actavis' former CEO is betting on biosimilars
Fierce Pharma
Friday, December 6, 2013 - 11:56am
tags:
Actavis, biosimilars, Alvogen
More Catalysts For MannKind
Seeking Alpha
Friday, December 6, 2013 - 11:12am
tags:
MannKind, Afrezza, diabetes, insulin
Smith & Nephew victory: Federal judge throws out metal-hip lawsuit
Fierce Medical Devices
Friday, December 6, 2013 - 10:33am
tags:
Smith & Nephew, devices, hip replacements
What Everybody Ought to Know About Gilead and Johnson & Johnson's New Hepatitis C Drugs
Seeking Alpha
Friday, December 6, 2013 - 10:30am
tags:
JNJ, Gilead Sciences, hepatitis C, sofosbuvir, Olysio, AbbVie, Bristol-Myers Squibb, Merck
Reckitt Benckiser Pharma Unit In The US Is Raided By The Feds
Pharmalot
Friday, December 6, 2013 - 10:28am
tags:
Reckitt Benckiser
Novartis aims to show strength with muscle wasting drug
Yahoo/Reuters
Friday, December 6, 2013 - 10:24am
tags:
muscle wasting, Novartis, sporadic inclusion body myositis, BYM338, MorphoSys
Keep a Close Watch on Geron, Keryx, and Sangamo Today
Motley Fool
Friday, December 6, 2013 - 10:21am
tags:
Geron, Keryx, Sangamo BioSciences
GSK, Theravance asthma drug shows improved lung function in study
Yahoo/Reuters
Friday, December 6, 2013 - 10:07am
tags:
GSK, Theravance, asthma
Geron Soars After Study Shows Bone Marrow Drug’s Benefit
Bloomberg
Friday, December 6, 2013 - 9:11am
tags:
Geron, imetelstat, myelofibrosis
Shire's new dry eye drug disappoints in pivotal trial
Yahoo/Reuters
Friday, December 6, 2013 - 9:04am
tags:
Shire, dry eye disease, Lifitegrast
Novartis bone marrow cancer drug meets goal in late-stage study
Yahoo/AP
Friday, December 6, 2013 - 9:01am
tags:
Novartis, LBH589, Multiple Myeloma
Better Earnings: Celgene, Biogen, Or Amgen?
Motley Fool
Friday, December 6, 2013 - 8:58am
tags:
Celgene, Biogen Idec, earnings, Amgen
Will Amarin And Arena See Better Sales In 2014?
Seeking Alpha
Thursday, December 5, 2013 - 6:59pm
tags:
Amarin, Arena Pharmaceuticals, Vascepa, Belviq
Flailing Transcept will liquidate if it can't find a buyer by Q2
Fierce Biotech
Thursday, December 5, 2013 - 6:55pm
tags:
Transcept

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.